DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma

SIMPLE SUMMARY: Patients with hepatocellular carcinoma are often monitored using serum markers such as alfa-fetoprotein. However, serum markers are not always accurate in predicting treatment success or the future course of the disease. In this research, we looked at the potential of DNA methylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chang-Yi, Hsiao, Chih-Yang, Peng, Pey-Jey, Huang, Shao-Chang, Chuang, Meng-Rong, Su, Hung-Ju, Huang, Kai-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527266/
https://www.ncbi.nlm.nih.gov/pubmed/37760434
http://dx.doi.org/10.3390/cancers15184465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527266/
https://www.ncbi.nlm.nih.gov/pubmed/37760434
http://dx.doi.org/10.3390/cancers15184465

Ejemplares similares